- Takeda Co. planning to sell its OTC medicine unit to U.S Blackstone Group Inc.
- Takeda plans on selling the same for around $2.9 billion.
- Takeda aims to reduce its debt of $5.86 billion after its purchase of Shire Plc.
- Blackstone Group has invested in real estate businesses and other companies in Japan.
Takeda Pharmaceutical Co. is currentl....
Tags : JAPAN, TAKEDA PHARMACEUTICAL CO., U.S BLACKSTONE GROUP INC., INVESTMENT FUND COMPANY, OVER-THE-COUNTER MEDICINE UNIT SALE, MEDICINE UNIT OF TAKEDA, TAKEDA CONSUMER HEALTHCARE CO.,